malaria
intrins
link
anophel
mosquito
minor
speci
appropri
vector
diseas
incid
influenc
interact
environment
factor
affect
vector
surviv
certain
characterist
plasmodium
spp
protozoan
parasit
caus
malaria
companion
human
speci
sinc
incept
start
long
journey
africa
year
ago
shape
popul
genet
behavior
like
organ
malaria
present
rang
mild
febril
ill
lifethreaten
diseas
multisystem
organ
failur
sever
malaria
belong
intens
care
unit
due
multitud
potenti
complic
remain
major
caus
mortal
worldwid
context
global
commun
chang
climat
border
relev
ever
decreas
critic
care
provid
familiar
diseas
equip
deliv
time
appropri
care
face
chang
epidemiolog
vector
like
resili
popul
densiti
effici
bite
habit
condit
natur
disast
war
poverti
potenti
anophelin
vector
speci
triumph
could
respons
ongo
endem
infect
certain
region
eg
anophel
gambia
complex
africa
human
attempt
partial
succeed
alter
balanc
although
preval
throughout
much
inhabit
world
world
war
ii
malaria
erad
unit
state
canada
europ
russia
nonetheless
persist
tropic
ensu
decad
improv
malaria
control
morbid
worsen
mani
area
due
resist
mosquito
insecticid
resist
parasit
antimalari
recent
new
larg
effort
control
eventu
erad
malaria
initi
includ
renew
way
deliv
insecticid
eg
impregn
net
indoor
residu
spray
prompt
treatment
prophylact
treatment
highrisk
group
led
document
decreas
level
morbid
mortal
part
africa
asia
oceania
rel
low
level
transmiss
intens
despit
effort
epidemiolog
chang
come
year
hard
predict
given
unproven
impact
measur
highli
endem
region
potenti
implic
climat
chang
million
case
death
attribut
malaria
identifi
remain
endem
countri
diseas
remain
disproportion
burden
tropic
subtrop
region
africa
asia
central
south
america
fig
children
pregnant
women
constitut
main
highrisk
group
first
one
accumul
death
second
one
suscept
signific
morbid
offspr
infect
p
falciparum
includ
mani
death
secondari
low
birth
weight
malaria
mortal
influenc
complex
interact
immun
specif
plasmodium
spp
virul
wherev
yearround
transmiss
p
falciparum
usual
primarili
involv
although
adult
usual
immun
children
remain
vulner
accumul
mortal
case
subsaharan
africa
world
health
organ
report
malaria
death
occur
region
asia
central
south
america
transmiss
intens
concentr
month
year
peopl
remain
suscept
adulthood
sinc
p
falciparum
p
vivax
similar
incid
mortal
lessen
later
region
influenc
chang
econom
social
environment
landscap
highli
endem
countri
effect
malaria
farreach
beyond
mortal
exert
major
toll
child
develop
signific
school
work
absente
way
million
dollar
lost
among
poorest
citizen
poorest
countri
world
interestingli
direct
correl
made
malaria
elimin
incom
growth
recogn
factor
includ
increas
product
foreign
invest
econom
network
within
countri
recent
decad
progress
increas
intern
travel
busi
tourism
consequ
progress
increas
tropic
diseas
diagnos
return
travel
among
malaria
common
document
caus
febril
ill
travel
return
tropic
develop
countri
repres
patient
present
specialist
patient
admit
hospit
unit
state
almost
case
occur
patient
recent
travel
region
ongo
transmiss
nonetheless
malaria
also
rare
transmit
import
parasit
transmit
local
anophelin
mosquito
blood
product
congenit
spread
infect
cdc
report
upgo
trend
case
malaria
report
unit
state
reduct
seen
attribut
chang
travel
pattern
face
ebola
outbreak
west
africa
fig
malaria
transmiss
known
occur
genu
plasmodium
encompass
speci
consid
infecti
human
be
p
falciparum
produc
highest
level
blood
parasitemia
sequest
key
tissu
main
caus
sever
malaria
p
vivax
usual
produc
milder
diseas
increasingli
recogn
caus
sever
malaria
well
especi
asia
south
america
two
sympatr
subspeci
p
oval
exist
po
curtisi
po
wallikeri
tend
produc
milder
diseas
p
malaria
speci
transmit
femal
anophel
mosquito
p
knowlesi
believ
mainli
zoonot
infect
transmit
macaqu
import
increasingli
recogn
especi
malaysia
coinfect
differ
speci
seen
case
femal
mosquito
carri
sporozoit
salivari
gland
may
determin
specif
feed
habit
includ
increas
attract
human
frequent
smaller
feed
motil
sporozoit
inocul
circul
liver
activ
infect
hepatocyt
caus
asymptomat
liver
infect
fig
invad
hepatocyt
matur
day
produc
schizont
schizont
ruptur
releas
thousand
merozoit
year
bloodstream
quickli
invad
erythrocyt
begin
asexu
erythrocyt
stage
fig
merozoit
develop
trophozoit
becom
schizont
period
h
case
p
falciparum
p
vivax
p
oval
h
case
p
malaria
h
case
p
knowlesi
schizont
ruptur
caus
hemolysi
releas
mani
merozoit
everi
cycl
caus
clinic
ill
erythrocyt
parasit
develop
sexual
gametocyt
taken
mosquito
femal
male
gametocyt
capabl
fuse
produc
zygot
multipl
step
sporozoit
gener
anophelin
salivari
gland
complet
cycl
p
vivax
p
oval
gener
hypnozoit
liver
lead
recurr
diseas
month
year
initi
infect
fig
key
pathogen
characterist
p
falciparum
abil
mediat
adher
infect
erythrocyt
endotheli
cell
erythrocyt
infect
matur
stage
parasit
remain
within
small
tissu
vessel
includ
brain
process
term
cytoadher
thought
caus
express
plasmodium
falciparum
erythrocyt
membran
protein
erythrocyt
membran
parasit
avoid
pass
spleen
abnorm
erythrocyt
would
clear
also
like
caus
local
tissu
damag
protein
member
var
famili
continu
chang
among
subtyp
impair
antigen
recognit
host
respons
moreov
subtyp
may
confer
tissu
specif
case
affin
endotheli
protein
c
receptor
cerebr
malaria
sever
diseas
associ
increas
parasitemia
higher
biomass
sequest
parasit
reinforc
previous
made
point
p
falciparum
life
cycl
requir
yeararound
transmiss
surviv
possibl
region
world
high
endem
rate
given
capabl
develop
hypnozoit
p
vivax
p
oval
inhabit
subtrop
area
mark
season
pattern
remain
dormant
optim
condit
met
human
immun
malaria
still
incomplet
understood
nonspecif
host
defens
mechan
control
infect
initi
humor
cellular
immun
thought
contribut
protect
endem
countri
p
falciparum
preval
diseas
occur
primarili
children
first
month
life
normal
spare
like
due
protect
confer
matern
antibodi
young
children
infect
frequent
experienc
repeat
febril
malaria
ill
high
risk
sever
diseas
repeat
exposur
children
develop
partial
immun
gradual
gain
protect
sever
malaria
increasingli
symptomat
ill
eventu
strong
protect
infect
nonetheless
antimalari
immun
incomplet
malaria
occur
individu
age
asymptomat
parasitemia
common
adult
older
children
live
area
high
transmiss
rate
import
underlin
occur
region
constant
exposur
yearround
absent
area
exposur
season
episod
corollari
adult
return
highli
endem
area
extend
stay
nonendem
area
increas
risk
diseas
shape
human
genet
much
malaria
erythrocyt
main
host
cell
plasmodium
speci
bodi
certain
chang
may
render
less
suscept
infect
specif
chang
hemoglobin
gener
environ
hostil
parasit
eg
decreas
parasit
growth
low
oxygen
tension
reduc
cytoadher
millennia
chang
accumul
certain
region
correspond
distribut
malaria
prior
modern
intervent
simultan
chang
shape
epidemiolog
plasmodium
probabl
best
exampl
p
vivax
mention
depend
presenc
duffi
antigen
erythrocyt
membran
popul
africa
accumul
mutat
render
erythrocyt
duffyneg
p
vivax
disappear
africa
locat
asia
central
south
america
case
malaria
includ
caus
p
falciparum
malaria
present
mild
febril
ill
incub
period
typic
day
p
falciparum
littl
longer
nonfalciparum
speci
incub
period
may
longer
patient
receiv
certain
antibiot
tetracyclin
trimethoprimsulfamethoxazol
quinolon
macrolid
inhabit
endem
area
nonfalciparum
malaria
like
present
highli
synchron
infect
lead
untreat
regular
cycl
fever
everi
p
vivax
p
oval
p
malaria
hour
often
minim
symptom
episod
nonspecif
symptom
common
like
headach
malais
myalgia
arthralgia
rigor
confus
nausea
vomit
diarrhea
abdomin
pain
etc
physic
exam
find
mayb
includ
sign
anemia
jaundic
splenomegali
mild
hepatomegali
may
well
absent
rash
lymphadenopathi
typic
malaria
trigger
suspicion
altern
possibl
laboratori
studi
commonli
show
anemia
thrombocytopenia
liver
renal
function
abnorm
sever
malaria
specif
definit
world
health
organ
applic
endem
nonendem
case
tabl
mostli
caus
p
falciparum
although
p
vivax
increasingli
recogn
caus
certain
region
sever
malaria
normal
rapidli
progress
diseas
one
seri
import
malaria
report
median
day
iqr
return
malariaendem
area
hospit
admiss
progress
sever
diseas
highli
variabl
best
avail
evid
report
mean
durat
symptom
day
icu
admiss
tropic
diseas
account
critic
care
admiss
certain
countri
asia
africa
south
america
critic
care
physician
area
world
familiar
differ
present
differ
infecti
agent
index
suspicion
high
baselin
peopl
travel
ever
expos
pathogen
often
present
upon
return
travel
modifi
base
rate
diseas
base
certain
epidemiolog
factor
one
hardest
thing
requir
diagnostician
framework
may
reduc
chang
experienc
bias
thorough
review
scope
chapter
astut
clinician
awar
import
understand
malaria
place
within
diagnost
schema
refer
interest
reader
specif
review
topic
great
exampl
recent
articl
fink
et
al
thwait
et
al
critic
carefocus
karnad
et
al
brief
differenti
diagnosi
sever
malaria
broad
vari
depend
specif
travel
histori
consid
local
foreign
caus
infecti
diseas
well
noninfecti
caus
fever
priorit
highli
contagi
diseas
like
hemorrhag
fever
measl
middl
eastern
respiratori
syndrom
impair
conscious
glasgow
coma
score
adult
blantyr
coma
score
children
prostrat
gener
weak
person
unabl
sit
stand
walk
without
assist
multipl
convuls
two
episod
within
h
acidosi
base
deficit
meql
avail
plasma
bicarbon
level
mmoll
venou
plasma
lactat
mmoll
sever
acidosi
manifest
clinic
respiratori
distress
rapid
deep
labor
breath
hypoglycemia
blood
plasma
glucos
mmoll
mgdl
sever
malari
anemia
hemoglobin
concentr
gdl
hematocrit
children
year
age
gdl
respect
adult
parasit
count
renal
impair
plasma
serum
creatinin
mgdl
blood
urea
mmoll
jaundic
plasma
serum
bilirubin
mgdl
parasit
count
pulmonari
edema
radiolog
confirm
oxygen
satur
room
air
respiratori
rate
often
chest
indraw
crepit
auscult
signific
bleed
includ
recurr
prolong
bleed
nose
gum
venepunctur
site
hematemesi
melena
shock
compens
shock
defin
capillari
refil
temperatur
gradient
leg
mid
proxim
limb
hypotens
decompens
shock
defin
systol
blood
pressur
mmhg
children
mmhg
adult
evid
impair
perfus
cool
peripheri
prolong
capillari
refil
hyperparasitemia
p
falciparum
parasitemia
adapt
world
health
organ
global
malaria
programm
coronaviru
viru
merscov
other
explor
book
obtain
detail
travel
histori
special
emphasi
locat
patient
might
visit
includ
layov
activ
hesh
engag
well
exposur
eg
mosquito
bite
fresh
water
sexual
commerc
incub
period
crucial
import
present
physic
examin
eg
conjunctiv
suffus
skin
rash
jaundic
hepatosplenomegali
probabl
relev
critic
care
physician
pattern
organ
involv
might
also
suggest
specif
etiolog
high
index
suspicion
essenti
diagnos
malaria
individu
febril
ill
risk
factor
investig
mention
common
identifi
caus
fever
return
travel
mani
area
world
keep
open
mind
possibl
key
attempt
perform
formal
diagnosi
tri
identifi
specif
plasmodium
speci
fig
thick
thin
blood
smear
continu
standard
care
procedur
one
drop
blood
allow
dri
slide
erythrocyt
lyse
parasit
stain
giemsa
parasit
easili
identifi
train
personnel
parasit
densiti
estim
basi
count
rel
leukocyt
howev
thick
blood
smear
allow
identif
erythrocyt
morpholog
help
speci
diagnosi
difficult
limit
train
giemsastain
thin
blood
smear
offer
improv
mean
character
parasit
morpholog
process
much
less
effici
thick
smear
thick
smear
standard
care
area
high
endem
burden
thin
reserv
area
train
personnel
time
avail
final
paramount
understand
neg
blood
film
exclud
malaria
might
well
posit
h
later
antigen
detect
new
way
diagnos
malaria
multipl
simpl
test
avail
use
calorimetr
detect
one
two
antigen
assay
requir
limit
train
minut
use
assay
africa
use
histidinerich
abl
detect
p
falciparum
assay
abl
detect
human
malari
speci
detect
lactat
dehydrogenas
aldolas
combin
test
aim
detect
p
falciparum
plasmodium
spp
avail
issu
aris
standard
given
heterogen
manufactur
test
avail
diagnost
techniqu
avail
includ
serolog
polymeras
chain
reaction
pcr
serolog
util
limit
sinc
antibodi
respons
slow
tend
persist
long
period
time
pcr
like
sensit
test
avail
date
use
research
purpos
nonetheless
scalabl
time
resourc
intens
furthermor
patient
might
clinic
signific
parasitemia
would
still
detect
outpati
therapi
might
approri
find
sever
malaria
sever
malaria
one
follow
shock
algid
malaria
may
due
gram
neg
becteraemia
earli
twentieth
centuri
pressur
find
substitut
quinin
treatment
malaria
led
discoveri
primaquin
quinacrin
final
chloroquin
unit
state
later
gener
use
make
drug
choic
end
world
war
ii
chloroquin
quickli
becam
one
import
drug
ever
develop
infecti
agent
key
understand
context
discoveri
ddt
vector
control
measur
optim
launch
erad
campaign
although
fell
short
cancel
extraordinari
impact
chloroquin
vulner
area
like
subsaharan
africa
undeni
widespread
use
without
consequ
p
falciparum
initi
found
develop
resist
foci
colombia
southeast
asia
resist
steadili
spread
final
get
africa
p
vivax
found
develop
resist
chloroquin
first
papua
new
guinea
found
asia
south
america
quinin
would
take
back
place
drug
choic
common
dose
depend
cinchon
nausea
vomit
blur
vision
revers
hear
loss
headach
despit
side
effect
like
hypoglycemia
would
remain
treatment
choic
first
trial
compar
artemisinin
deriv
publish
artemisin
deriv
chines
herb
qinghausu
wormwood
use
chines
tradit
healer
millennia
adopt
western
world
recent
year
one
deriv
artesun
recent
found
two
larg
random
control
trial
superior
quinin
seaquamat
random
patient
south
southeast
asia
almost
adult
found
reduct
mortal
patient
treat
artesun
compar
quinin
vs
subsequ
aquamat
focus
children
countri
subsaharan
africa
demonstr
similar
reduct
mortal
vs
acut
set
treat
sever
malaria
intraven
quinin
therapi
requir
close
monitor
qtc
interv
well
capillari
blood
glucos
artesun
safe
regard
nonetheless
latter
use
singl
agent
due
short
biolog
halflif
lead
prompt
recrudesc
avail
artesun
limit
special
center
access
might
prove
challeng
import
recogn
treatment
quinin
delay
attempt
obtain
artesun
outpati
consolid
treatment
artemisin
combin
treatment
act
standard
care
p
falciparum
recommend
regimen
treatment
combin
artesun
activ
antimalari
agent
daili
eg
artesunatemefloquin
other
requir
twicedaili
dose
eg
artemetherlumefantrin
therapi
use
everi
patient
confirm
p
falciparum
speci
involv
doubt
initi
administr
parenter
artesun
chloroquin
remain
treatment
choic
nonfalciparum
malaria
area
regist
resist
primarili
central
america
caribbean
p
vivax
p
oval
alway
given
erad
hepat
hypnozoit
also
chloroquinerel
compound
found
act
activ
p
falciparum
develop
resist
quinin
rel
slow
use
two
centuri
time
first
resist
first
describ
comparison
chloroquin
proguanil
took
year
respect
quinin
resist
extens
document
asia
south
america
seem
rel
uncommon
africa
quinin
normal
retain
efficaci
although
activ
might
delay
diminish
recent
metaanalysi
multipl
random
clinic
trial
demonstr
recrudesc
rate
quinin
treatment
rel
stabl
year
side
effect
drawback
point
quinin
seem
remain
viabl
treatment
option
artesun
resist
first
report
western
cambodia
confirm
random
control
trial
character
decreas
clearanc
parasit
vivo
hardli
sign
suscept
vitro
note
rapid
parasit
elimin
one
main
advantag
artemisin
therapi
account
signific
part
rapid
therapeut
respons
could
drastic
affect
outcom
sadli
continu
report
area
southeast
asian
subcontin
worrisom
laboratori
data
point
possibl
extrem
artemisin
resist
appropri
vitro
condit
accompani
complex
pattern
multipl
drug
resist
content
resist
strain
judici
use
current
avail
therapi
multipl
agent
regimen
face
clinic
failur
measur
avail
septic
patient
treatment
immedi
follow
concurr
treatment
stabil
patient
isol
treat
caus
agent
parenter
antimalari
imper
although
p
vivax
p
knowlesi
increasingli
recogn
caus
sever
malaria
p
falciparum
assum
caus
agent
proven
otherwis
aggress
fluid
resuscit
consid
intrins
part
initi
sepsi
manag
evid
mount
might
detriment
patient
malaria
due
differ
pathogenesi
increas
vascular
permeabl
adult
malaria
base
deficit
strongest
predictor
mortal
degre
acut
kidney
injuri
aki
addit
risk
factor
hypovolemia
present
sever
malaria
exacerb
condit
nonetheless
microvascular
patholog
malaria
uniqu
sinc
impair
tissu
perfus
mostli
caus
sequestr
infect
erythrocyt
degre
acidosi
aki
intrins
relat
sequestr
especi
kidney
liver
increas
evid
fluid
resuscit
revers
patholog
process
recent
feast
trial
suggest
among
subsaharan
african
children
particular
definit
shock
salin
albumin
bolu
resuscit
appear
increas
mortal
compar
nobolu
strategi
malaria
reason
admiss
children
hard
translat
result
directli
resourcerich
countri
might
safe
assum
time
present
hospit
might
prolong
well
potenti
effect
absenc
tool
like
mechan
ventil
moreov
children
sever
malaria
rare
develop
aki
oppos
adult
patient
evid
mount
fluid
resuscit
might
detriment
even
close
monitor
complet
differ
studi
evalu
liber
vs
conserv
fluid
strategi
monitor
extracellular
water
wellvalid
tool
even
though
hypovolem
patient
recruit
acidbas
statu
deterior
reason
amount
fluid
mean
ml
first
h
pulmonari
edemasecondari
increas
pulmonari
vascular
permeabilitywa
common
unpredict
exacerb
fluid
load
lactat
strongest
mortal
predictor
correl
degre
visual
microvascular
sequestr
parasit
erythrocyt
ie
decreas
flow
veloc
orthogon
polar
spectroscopi
impact
fluid
resuscit
fact
patient
acidbas
statu
deterior
fluid
resuscit
multipl
studi
associ
fluid
resuscit
wors
outcom
malaria
beyond
earli
initi
antimalari
recommend
overzeal
liber
fluid
resuscit
rapid
escal
vasopressor
therapi
hemodynam
manag
clinician
vigil
variou
complic
associ
increas
vascular
permeabl
seen
diseas
standard
therapi
sever
malaria
parenter
quinin
continu
cardiac
monitor
mention
evid
mount
artesun
superior
term
efficaci
safeti
profil
avail
still
major
issu
unit
state
iv
quinin
avail
hospit
iv
artesun
request
name
patient
basi
center
diseas
control
treatment
start
whatev
agent
may
administ
first
tabl
three
initi
dose
patient
toler
oral
rout
receiv
oral
medic
includ
regimen
mention
adjunct
measur
exchang
transfus
propos
treatment
sever
falciparum
malaria
although
seem
address
issu
core
evid
support
use
still
lack
sever
case
report
document
success
use
retrospect
review
avail
show
improv
parasit
clearanc
outcom
cerebr
malaria
common
children
africa
patient
may
present
stupor
coma
seizur
decerebr
postur
rais
intracrani
pressur
strictli
cerebr
malaria
defin
coma
gc
patient
malaria
caus
rule
broadli
patient
alter
mental
statu
presum
cerebr
malaria
rule
common
caus
like
hypoglycemia
cerebr
malaria
associ
wors
outcom
patient
cerebr
malaria
subclin
seizur
although
prophylact
anticonvuls
reduc
seizur
incid
metaanalysi
show
may
fact
worsen
outcom
main
critic
trial
report
thu
far
mainli
done
phenobarbit
increas
mortal
attribut
respiratori
depress
whether
use
antiepilept
use
remain
determin
regardless
current
evid
discourag
routin
electroencephalogram
monitor
use
prophylact
phenobarbit
clinic
seizur
treat
appropri
cerebr
edema
wellrecogn
complic
sever
malaria
multipl
intervent
test
random
clinic
trial
without
success
includ
steroid
mannitol
adjunct
therapi
current
recommend
cerebr
malaria
moment
anemia
patient
malaria
hemolyt
process
also
involv
dyserythropoiesi
remov
infect
erythrocyt
circul
spleen
uninfect
erythrocyt
indirectli
affect
antigen
antibodi
activ
minor
alter
red
cell
membran
defin
sever
anemia
hgb
mgdl
howev
degre
anemia
mainli
seen
endem
area
like
multifactori
except
rare
import
case
transfus
threshold
current
critic
ill
patient
coagulopathi
seen
patient
sever
malaria
sever
thrombocytopenia
common
sever
nonsever
malaria
secondari
increas
platelet
destruct
sequestr
within
spleen
dissemin
intravascular
coagul
occur
patient
treat
support
transfus
lactic
acidosi
marker
poor
prognosi
attribut
mainli
microvascular
obstruct
secondari
parasit
cytoadher
lead
hypoperfus
factor
contribut
thought
direct
product
lactat
parasit
decreas
clearanc
set
liver
dysfunct
point
differ
type
lactic
acidosi
treat
would
might
result
deleteri
effect
hypoglycemia
defin
blood
sugar
mgdl
mmoll
common
sever
malaria
associ
wors
outcom
special
children
seem
applic
import
case
malaria
although
preval
smaller
correl
wors
outcom
pathogenesi
incomplet
understood
like
involv
direct
glucos
consumpt
parasit
well
impair
gluconeogenesi
liver
pair
hyperinsulinemia
also
shown
frequent
patient
treat
quinin
compar
artesun
combin
hr
clinic
featur
includ
decreas
level
conscious
seizur
blood
glucos
regularli
assess
special
patient
treat
quinin
earli
enter
feed
recommend
critic
ill
patient
could
particularli
benefici
patient
malaria
includ
pulmonari
manifest
malaria
deep
breath
respiratori
distress
pulmonari
edema
tachypnea
might
caus
fever
anemia
metabol
acidosi
also
primari
lung
patholog
like
pulmonari
edema
acut
respiratori
distress
syndrom
ard
report
incid
ard
vari
part
due
use
differ
definit
rang
common
adult
compar
children
portend
wors
prognosi
pulmonari
complic
malaria
attribut
direct
toxic
cytoadher
p
falciparum
pair
hyperact
host
respons
concurr
bacteria
pneumonia
pulmonari
edema
import
caus
respiratori
distress
popul
acut
kidney
injuri
aki
mainli
associ
p
falciparum
although
describ
speci
use
differ
criterion
mmoll
mgdl
qualifi
sever
malaria
current
use
diseas
interestingli
acut
kidney
injuri
frequent
patient
primoinfect
aki
much
frequent
patient
import
malaria
rang
compar
endem
case
pathophysiolog
like
multifactori
cytoadher
glomerular
tubular
vasculatur
like
play
major
role
contribut
hypovolemia
hemolysi
immunecomplex
deposit
cytokin
releas
patient
screen
aki
may
absent
initi
discov
treatment
mainli
support
avoid
nephrotox
agent
mainten
fluid
control
electrolyt
acidbas
disturb
includ
renal
replac
therapi
indic
improv
perfus
dopamin
epinephrin
test
fail
improv
renal
outcom
prognosi
usual
good
complet
resolut
case
upon
infect
control
hyperbilirubinemia
multifactori
may
occur
set
hemolysi
cholestasi
hepatocyt
dysfunct
bilirubin
significantli
elev
transaminas
normal
less
affect
cohort
critic
ill
patient
krishnan
et
al
found
hyperbilirubinemia
mgdl
seen
patient
transaminas
level
three
time
upper
limit
normal
seen
less
half
patient
elev
transaminas
higher
incid
hypoglycemia
wors
mortal
endem
area
concurr
gramneg
infect
especi
nontyphoid
salmonella
shown
children
commun
studi
point
two
third
commun
bacteremia
relat
coinfect
malaria
happen
associ
wors
prognosi
rate
communityacquir
bacteri
infect
report
patient
admit
intens
care
unit
import
case
malaria
communityacquir
pneumonia
commonest
use
prophylact
antibiot
remain
controversi
bacteri
coinfect
suspect
patient
signific
neutrophilia
focal
sign
infect
case
blood
cultur
drawn
therapi
deescal
tailor
base
cultur
result
critic
ill
patient
physician
remain
vigil
nosocomi
infect
includ
ventilatorassoci
pneumonia
catheterrel
sepsi
common
stewardship
practic
ie
monitor
extub
readi
limit
use
urinari
cathet
appli
similar
manner
patient
p
falciparum
malaria
tend
respond
well
treatment
start
promptli
mortal
rate
uncompl
p
falciparum
nonetheless
critic
care
popul
highlevel
parasitemia
clinic
featur
might
determin
wors
outcom
howev
aggress
support
even
individu
sever
diseas
often
experi
complet
recoveri
exampl
mark
et
al
report
mortal
antinori
et
al
mortal
moreov
nonfalciparum
malaria
usual
respond
well
treatment
make
unev
recoveri
resist
emerg
chang
epidemiolog
might
greatest
challeng
face
futur
judici
use
exist
therapi
care
monitor
attent
cooccur
complic
help
us
navig
chang
landscap
treatment
malaria
critic
care
unit
